The Analgesic Efficacy of Pericapsular Nerve Group (PENG) Block in Patients Undergoing Primary Total Hip Arthoplasty:

Recruiting N/A Interventional Study
Prospective Randomized Double-blind
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
110 (estimated)
Sponsor
Diakonie-Klinikum Stuttgart · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The aim of this study is to investigate the analgesic efficacy of the pericapsular nerve group (PENG) block during the implantation of hip endoprostheses. The study is designed as a prospective randomized double-blind study and the study participants were randomized into 2 arms and either 20 ml ropivacaine 0.5% (verum group) or 20 ml physiological saline solution (placebo group) will be applied.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * planned cementless hip TEP operation for primary coxarthrosis via minimally invasive anterolateral approach using the identical implant system (Taperloc stem, Plamafit cup) * Patient capable of giving consent * Informed consent has been obtained * age \> 18 years Exclusion Cr…
Contacts

Rainer Meierhenrich, Prof. Dr.

00497119912290

meierhenrich@diak-stuttgart.de

CONTACT